Covered recipient · General Payments record
HANNAH LEE SHELBY-KENNEDY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,231.41
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $447.88 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $311.30 | 19 |
| Amgen Inc. | $61.81 | 3 |
| ABBVIE INC. | $36.71 | 2 |
| GlaxoSmithKline, LLC. | $22.58 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.51 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081211 | CMS |
| ABBVIE INC. | $17.20 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106081213 | CMS |
| Amgen Inc. | $20.12 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381210 | CMS |
| Amgen Inc. | $21.08 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381212 | CMS |
| Amgen Inc. | $20.61 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117381214 | CMS |
| GlaxoSmithKline, LLC. | $22.58 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116483407 | CMS |
| Novo Nordisk Inc | $18.02 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096858161 | CMS |
| Novo Nordisk Inc | $14.67 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097480394 | CMS |
| Novo Nordisk Inc | $12.54 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097359978 | CMS |
| Novo Nordisk Inc | $20.11 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096579379 | CMS |
| Novo Nordisk Inc | $12.54 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097000486 | CMS |
| Novo Nordisk Inc | $15.96 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097301562 | CMS |
| Novo Nordisk Inc | $18.62 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097208570 | CMS |
| Novo Nordisk Inc | $16.53 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097166048 | CMS |
| Novo Nordisk Inc | $17.80 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096680762 | CMS |
| Novo Nordisk Inc | $18.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096846564 | CMS |
| Novo Nordisk Inc | $18.50 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097190583 | CMS |
| Novo Nordisk Inc | $17.81 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097504511 | CMS |
| Novo Nordisk Inc | $12.54 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097355935 | CMS |
| Novo Nordisk Inc | $15.96 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097430257 | CMS |
| Novo Nordisk Inc | $16.52 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097589906 | CMS |
| Novo Nordisk Inc | $16.64 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096925448 | CMS |
| Novo Nordisk Inc | $12.96 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097004134 | CMS |
| Novo Nordisk Inc | $18.92 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096718013 | CMS |
| Novo Nordisk Inc | $16.19 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097217112 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.48 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153624341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.